RUNX3 and basal cell carcinoma: Although we found that RUNX3 functioned as a tumor suppressor in gastric cancer, it was reported that RUNX3 served as an oncogene in epithelial ovarian cancer, basal cell carcinoma, and head and neck squamous cell carcinoma.